Area of research
Psychiatry and Mental health · Physiology
Research interest
Research interests include Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments, Functional Brain Connectivity Studies, and Neural and Behavioral Psychology Studies.
Pre-treatment seizures and cognition at the time of focal epilepsy diagnosis
Brain aging patterns in a large and diverse cohort of 49,482 individuals
Genetic and Clinical Correlates of AI-Based Brain Aging Patterns in Cognitively Unimpaired Individuals
Clearance and transport of amyloid β by peripheral monocytes correlate with Alzheimer’s disease progression
Genetic and clinical correlates of two neuroanatomical AI dimensions in the Alzheimer’s disease continuum
Engagement in online cognitive testing with the Cogstate brief battery among a multinational cohort of people with focal epilepsy
Evaluation of effect of cooled haemodialysis on cognition in patients with end-stage kidney disease (ECHECKED) feasibility randomised controlled trial results
Genomic loci influence patterns of structural covariance in the human brain
Alzheimer’s disease genetic risk and cognitive reserve in relationship to long-term cognitive trajectories among cognitively normal individuals
Plasma Aβ42/40 ratio, p‐tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross‐sectional and longitudinal study in the AIBL cohort
Why a clinical trial is as good as its outcome measure: A framework for the selection and use of cognitive outcome measures for clinical trials of Alzheimer's disease
Preclinical and randomized clinical evaluation of the p38α kinase inhibitor neflamapimod for basal forebrain cholinergic degeneration
Harmonizing the preclinical Alzheimer cognitive composite for multicohort studies.
A deep learning framework identifies dimensional representations of Alzheimer’s Disease from brain structure
MRI signatures of brain age and disease over the lifespan based on a deep brain network and 14 468 individuals worldwide
Risk prediction of late-onset Alzheimer’s disease implies an oligogenic architecture
The Brain Chart of Aging: Machine‐learning analytics reveals links between brain aging, white matter disease, amyloid burden, and cognition in the iSTAGING consortium of 10,216 harmonized MR scans
Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and <i>APOE</i> genotype
Harmonization of large MRI datasets for the analysis of brain imaging patterns throughout the lifespan
Clinical meaningfulness of subtle cognitive decline on longitudinal testing in preclinical AD
A Qualitative Study on the Transition Support Needs of Indigenous Australians Following Traumatic Brain Injury
F1‐03‐03: DISTINCT CONTRIBUTIONS OF BASELINE AND LONGITUDINAL AMYLOID PET MEASURES TO MEMORY DECLINE IN COGNITIVELY NORMAL OLDER ADULTS
P3‐031: CLINICAL MEANINGFULNESS OF SHORT‐TERM COGNITIVE DECLINE ON THE PRECLINICAL ALZHEIMER'S COGNITIVE COMPOSITE‐5 (PACC‐5) IN NORMAL OLDER ADULTS WITH ELEVATED β‐AMYLOID
F2‐03‐01: CLINICAL MEANINGFULNESS OF SHORT‐TERM COGNITIVE DECLINE ON THE PRECLINICAL ALZHEIMER'S COGNITIVE COMPOSITE‐5 (PACC‐5) IN NORMAL OLDER ADULTS WITH ELEVATED β‐AMYLOID
Recommendations for the nomenclature of cognitive change associated with anaesthesia and surgery—2018
Subjective cognitive decline and rates of incident Alzheimer's disease and non–Alzheimer's disease dementia
Sex, amyloid, and <i>APOE</i> ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well‐characterized cohorts
The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease: Perspectives from the Research Roundtable
Safety, tolerability and efficacy of the glutaminyl cyclase inhibitor PQ912 in Alzheimer’s disease: results of a randomized, double-blind, placebo-controlled phase 2a study
Unsupervised online neuropsychological test performance for individuals with mild cognitive impairment and dementia: Results from the Brain Health Registry